Cancer-related fatigue: Definitions and clinical subtypes

JNCCN Journal of the National Comprehensive Cancer Network

Volumn 8, Issue 8, 2010, Pages 958-966

  Piper, Barbara F ^a   Cella, David ^b  

^a UNIVERSITY OF ARIZONA   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Cancer related fatigue; Case definitions; Cut scores; Definitions; Genotypes; Phenotypes; Subtypes; Symptom clusters

Indexed keywords

ANTHRACYCLINE DERIVATIVE; ANTINEOPLASTIC AGENT;

ANEMIA; BRAIN CANCER; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER FATIGUE; CANCER PAIN; CANCER PATIENT; CANCER RADIOTHERAPY; CIRCADIAN RHYTHM; COMORBIDITY; DEPRESSION; DISEASE SEVERITY; ENERGY; FATIGUE; GENETIC VARIABILITY; GENOTYPE; HUMAN; INSOMNIA; LUNG CANCER; MULTIPLE CYCLE TREATMENT; PHENOTYPE; PROSTATE CANCER; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 77957376206     PISSN: 15401405     EISSN: 15401413     Source Type: Journal    
DOI: 10.6004/jnccn.2010.0070     Document Type: Review

References (79)

1. Berger AM, Abernathy, AP, Atkinson, A, et al. NCCN clinical practice guidelines in oncology: cancer-related fatigue. Version 1, 2010. Available at: http://www.nccn.org/professionala/physician-gls/PDF/fatigue.pdf. Accessed June 1, 2010.
2. Clinical Care Options. Cancer-related fatigue. Available at: http://www.clinicaloptions.com/inPractice/Oncology/Supportive-Care/ ch48-SuppCare-Fatigue.aspx. Accessed February 15, 2010.
3. Jean-Pierre P, Figueroa-Moseley CD, Kohli S, et al. Assessment of cancer-related fatigue: implications for clinical diagnosis and treatment. Oncologist 2007;12(Suppl 1):11-21.
4. Kangas M, Bovbjerg DH, Montgomery GH. Cancer-related fatigue: a systematic and meta-analytic review of non-pharmacological therapies for cancer patients. Psychol Bull 2008;134:700-741.
5. Lynch J, Mead G, Greig C, et al. Fatigue after stroke: the development and evaluation of a case definition. J Psychosom Res 2007;63:539-544. (Pubitemid 350007669)
6. Cella D, Peterman A, Passik S, et al. Progress toward guidelines for the management of fatigue. Oncology (Williston Park) 1998;12:369-377.
7. Cella D, Davis K, Breitbart W, et al. Cancer-related fatigue: prevalence of proposed diagnostic criteria in a United States sample of cancer survivors. J Clin Oncol 2001;19:3385-3391.
8. Sadler IJ, Jacobsen P, Booth-Jones M, et al. Preliminary evaluation of a clinical syndrome approach to assessing cancer-related fatigue. J Pain Symptom Manage 2002;23:406-416.
9. Fernandes R, Stone P, Andrews P, et al. Comparison between fatigue, sleep disturbance, and circadian rhythm in cancer inpatients and healthy volunteers: evaluation of diagnostic criteria for cancer-related fatigue. J Pain Symptom Manage 2006;32:245-254. (Pubitemid 44291519)
10. Murphy H, Alexander S, Stone P. Investigation of diagnostic criteria for cancer-related fatigue syndrome in patients with advanced cancer: a feasibility study. Palliat Med 2006;20:413-418.
11. Van Belle S, Paridaens R, Evers G, et al. Comparison of proposed diagnostic criteria with FACT-F and VAS for cancer-related fatigue: proposal for use as a screening tool. Support Care Cancer 2005;13:246-254.
12. Bennett B, Goldstein D, Friedlander M, et al. The experience of cancer-related fatigue and chronic fatigue syndrome: a qualitative and comparative study. J Pain Symptom Manage 2007;34:126-135. (Pubitemid 47096778)
13. Mendoza TR, Wang XS, Cleeland CS, et al. The rapid assessment of fatigue severity in cancer patients: use of the brief fatigue inventory. Cancer 1999;85:1186-1196.
14. Borneman T, Koczywas M, Sun V, et al. Reducing barriers to pain and fatigue management. J Pain Symptom Manage 2010;38:486-501.
15. Meeske K, Smith AW, Alfano CM, et al. Fatigue in breast cancer survivors two to five years post diagnosis: a HEAL study report. Qual Life Res 2007;16:947-960.
16. Jeon S, Given CW, Sikorskii A, Given B. Do interference-based cut-points differentiate mild, moderate, and severe levels of 16 cancer-related symptoms over time? J Pain Symptom Manage 2009;37:220-232.
17. Butt Z, Wagner LI, Beaumont JL, et al. Use of a single-item screening tool to detect clinically significant fatigue, pain, distress, and anorexia in ambulatory cancer practice. J Pain Symptom Manage 2008;35:20-30.
18. Cella D, Lai JS, Chang CH, et al. Fatigue in cancer patients compared with fatigue in the general united states population. Cancer 2002;94:528-538.
19. Hinds PS, Yang Y, Gattuso JS, et al. Psychometric and clinical assessment of the 10-item reduced version of the fatigue scale-child instrument. J Pain Symptom Manage 2010;39:572-578.
20. Chang YJ, Lee JS, Lee CG, et al. Assessment of clinical relevant fatigue level in cancer. Support Care Cancer 2007;15:891-896.
21. Wielgus KK, Berger AM, Hertzog M. Predictors of fatigue 30 days after completing anthracycline plus taxane adjuvant chemotherapy for breast cancer. Oncol Nurs Forum 2009;36:38-48.
22. Hofman M, Ryan JL, Figueroa-Moseley CD, et al. Cancer-related fatigue: the scale of the problem. Oncologist 2007;12(Suppl 1):4-10.
23. Doorenbos A, Given B, Given C, et al. Reducing symptom limitations: a cognitive behavioral intervention randomized trial. Psychooncology 2005;14:574-584. (Pubitemid 41025283)
24. Given B, Given CW, Sikorskii A, et al. Establishing mild, moderate, and severe scores for cancer-related symptoms: how consistent and clinically meaningful are interference-based severity cut-points? J Pain Symptom Manage 2008;35:126-135.
25. Revicki D, Hays R, Cella D, Sloan J. Recommended methods for determining responsiveness and minimally important differences for patient reported outcomes. J Clin Epi 2008;61:102-109.
26. Sloan J, Cella D, Hays R. Clinical significance of patient-reported questionnaire data: another step toward consensus. J Clin Epi 2005;58:1217-1219.
27. Miaskowski C, Dodd M, West C, et al. The use of a responder analysis to identify differences in patient outcomes following a self-care intervention to improve cancer pain management. Pain 2007;129:55-63.
28. Miaskowski C, Cooper BA, Paul SM, et al. Subgroups of patients with cancer with different symptom experiences and quality-of-life outcomes: a cluster analysis. Oncol Nurs Forum 2006;33:E79-89.
29. Olson K. A new way of thinking about fatigue: a reconceptualizat ion. Oncol Nurs Forum 2007;34:93-98.
30. Davies B, Whitsett SF, Bruce A, McCarthy P. A typology of fatigue in children with cancer. J Pediatr Oncol Nurs 2002;19:12-21.
31. Teunissen SC, Wesker W, Kruitwagen C, et al. Symptom prevalence in patients with incurable cancer: a systematic review. J Pain Symptom Manage 2007;34:94-104. (Pubitemid 46970881)
32. Francoeur RB. The relationship of cancer symptom clusters to depressive affect in the initial phase of palliative radiation. J Pain Symptom Manage 2005;29:130-155.
33. Bower JE, Ganz PA, Desmond KA, et al. Fatigue in breast cancer survivors: occurrence, correlates, and impact on quality of life. J Clin Oncol 2000;18:743-753.
34. Bower JE, Ganz PA, Aziz N, et al. T-cell homeostasis in breast cancer survivors with persistent fatigue. J Natl Cancer Inst 2003;95:1165-1168.
35. Collado-Hidalgo A, Bower JE, Ganz PA, et al. Cytokine gene polymorphisms and fatigue in breast cancer survivors: early findings. Brain Behav Immun 2008;22:1197-1200.
36. Richardson A, Ream E, Wilson-Barnett J. Fatigue in patients receiving chemotherapy: patterns of change. Cancer Nurs 1998;21:17-30. (Pubitemid 28114404)
37. Berger AM. Patterns of fatigue and activity and rest during adjuvant breast cancer chemotherapy. Oncol Nurs Forum 1998;25:51-62.
38. Berger AM, Lockhart K, Agrawal S. Variability of patterns of fatigue and quality of life over time based on different breast cancer adjuvant chemotherapy regimens. Oncol Nurs Forum 2009;36:563-570.
39. Dimsdale JE, Ancoli-Israel S, Ayalon L, et al. Taking fatigue seriously, II: variability in fatigue levels in cancer patients. Psychosomatics 2007;48:247-252.
40. Miaskowski C, Paul SM, Cooper BA, et al. Trajectories of fatigue in men with prostate cancer before, during, and after radiation therapy. J Pain Symptom Manage 2008;35:632-643.
41. Dhruva A, Dodd M, Paul SM, et al. Trajectories of fatigue in patients with breast cancer before, during, and after radiation therapy. Cancer Nurs 2010;33:201-212.
42. Hauser K, Walsh D, Rybicki LA, et al. Fatigue in advanced cancer: a prospective study. Am J Hosp Palliat Care 2008;25:372-378.
43. Given CW, Given B, Azzouz F, et al. Predictors of pain and fatigue in the year following diagnosis among elderly cancer patients. J Pain Symptom Manage 2001;21:456-466. (Pubitemid 32492931)
44. Reyes-Gibby CC, Aday LA, Anderson KO, et al. Pain, depression, and fatigue in community-dwelling adults with and without a history of cancer. J Pain Symptom Manage 2006;32:118-128.
45. Barsevick AM. The elusive concept of the symptom cluster. Oncol Nurs Forum 2007;34:971-980.
46. Prue G, Rankin J, Allen J, et al. Cancer-related fatigue: a critical appraisal. Eur J Cancer 2006;42:846-863.
47. Dodd MJ, Miaskowski C, Lee KA. Occurrence of symptom clusters. J Natl Cancer Inst Monogr 2004:76-78.
48. Dodd MJ, Cho MH, Cooper B, et al. Advancing our knowledge of symptom clusters. J Support Oncol 2005;3(6 Suppl 4):30-31.
49. Bower JE. Cancer-related fatigue: links with inflammation in cancer patients and survivors. Brain Behav Immun 2007;21:863-871.
50. Hockenberry MJ, Hooke MC, Gregurich MA, et al. Symptom clusters in children and adolescents receiving cisplatin, doxorubicin, or ifosfamide. Oncol Nurs Forum 2010;37:E16-27.
51. Chiang YC, Yeh CH, Wang KW, Yang CP. The experience of cancer-related fatigue in Taiwanese children. Eur J Cancer Care 2007;18:43-49.
52. Cleeland CS, Bennett GJ, Dantzer R, et al. Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism? A cytokine-immunologic model of cancer symptoms. Cancer 2003;97:2919-2925.
53. Payne JK. A neuroendocrine-based regulatory fatigue model. Biol Res Nurs 2004;6:141-150.
54. Payne J, Piper BF, Rabinowitz I, Zimmerman B. Biomarkers, fatigue, sleep, and depressive symptoms in women with breast cancer: a pilot study. Oncol Nurs Forum 2006;33:775-783.
55. Musselman DL, Miller AH, Porter MR, et al. Higher than normal plasma interleukin-6 concentrations in cancer patients with depression: preliminary findings. Am J Psychiatry 2001;158:1252-1257.
56. Cleeland CS, Reyes-Gibby CC. When is it justified to treat symptoms? Measuring symptom burden. Oncology (Williston Park) 2002;16(9 Suppl 10):64-70.
57. Fan G, Filipczak L, Chow E. Symptom clusters in cancer patients: a review of the literature. Curr Oncol 2007;14:173-179.
58. Skerman HM, Yates PM, Battistutta D. Multivariate methods to identify cancer-related symptom clusters. Res Nurs Health 2009;32:345-360.
59. Kim HJ, Abraham IL. Statistical approaches to modeling symptom clusters in cancer patients. Cancer Nurs 2008;31:E1-10.
60. Huang TW, Lin CC. The mediating effects of depression on sleep disturbance and fatigue: symptom clusters in patients with hepatocellular carcinoma. Cancer Nurs 2009;32:398-403.
61. Beck SL, Dudley WN, Barsevick A. Pain, sleep disturbance, and fatigue in patients with cancer: using a mediation model to test a symptom cluster. Oncol Nurs Forum 2005;32:542.
62. Barsevick AM, Dudley WN, Beck SL. Cancer-related fatigue, depressive symptoms, and functional status: a mediation model. Nurs Res 2006;55:366-372.
63. Doorenbos AZ, Verbitsky N, Given B, Given CW. An analytic strategy for modeling multiple-item responses: a breast cancer symptom example. Nurs Res 2005;54:229-234. (Pubitemid 41097414)
64. Barsevick AM, Whitmer K, Nail LM, et al. Symptom cluster research: conceptual, design, measurement, and analysis issues. J Pain Symptom Manage 2006;31:85-95.
65. Gift AG, Stommel M, Jablonski A, Given W. A cluster of symptoms over time in patients with lung cancer. Nurs Res 2003;52:393-400.
66. Hayduk L, Olson K, Quan H, et al. Temporal changes in the causal foundations of palliative care symptoms. Qual Life Res 2010;19:299-306.
67. Olson K, Hayduk L, Cree M, et al. The changing causal foundations of cancer-related symptom clustering during the final month of palliative care: a longitudinal study. BMC Med Res Methodol 2008;8:1-11.
68. Pud D, Ben Ami S, Cooper BA, et al. The symptom experience of oncology outpatients has a different impact on quality-of-life outcomes. J Pain Symptom Manage 2008;35:162-170.
69. Kozachik SL, Bandeen-Roche K. Predictors of patterns of pain, fatigue, and insomnia during the first year after a cancer diagnosis in the elderly. Cancer Nurs 2008;31:334-344.
70. Dirksen SR, Belyea MJ, Epstein DR. Fatigue-based subgroups of breast cancer survivors with insomnia. Cancer Nurs 2009;32:404-411.
71. Liu L, Fiorentino L, Natarajan L, et al. Pre-treatment symptom cluster in breast cancer patients is associated with worse sleep, fatigue and depression during chemotherapy. Psychooncology 2009;18:187-194.
72. Schubert C, Hong S, Natarajan L, et al. The association between fatigue and inflammation marker levels in cancer patients: a quantitative review. Brain Behav Immun 2007:21:413-427. (Pubitemid 46528677)
73. Aouizerat B, Dodd M, Lee K, et al. Preliminary evidence of a genetic association between tumor necrosis factor alpha and the severity of sleep disturbance and morning fatigue. Biol Res Nurs 2009;11:27-41.
74. Reyes-Gibby CC, Wu X, Spitz M, et al. Molecular epidemiology, cancer-related symptoms, and cytokines pathway. Lancet Oncol 2008;9:777-785. (Pubitemid 352038316)
75. Landmark-Hoyvik H, Reinertsen KV, Loge JH, et al. Alterations of gene expression in blood cells associated with chronic fatigue in breast cancer survivors. Pharmacogenomics J 2009;9:333-340.
76. Sloan JA, Zhao, CX. Genetics and quality of life. Curr Probl Cancer 2006;30:255-260.
77. Piper BF, Borneman T, Sun VC, et al. Cancer-related fatigue: role of oncology nurses in translating national comprehensive cancer network assessment guidelines into practice. Clin J Oncol Nurs 2008;12(5 Suppl):37-47.
78. Whitsett SF, Gudmundsdottir M, Davies B, et al. Chemotherapy-related fatigue in childhood cancer: correlates, consequences, and coping strategies. J Pediatr Oncol Nurs 2008;25:86-96.
79. Sprangers MA, Sloan JA, Veenhoven R, et al. The establishment of the GENEQOL consortium to investigate the genetic disposition of patient-reported quality-of-life outcomes. Twin Res Hum Genet 2009;12:301-311.